SMS Pharmaceuticals
SMSPHARMA · Pharma > Pharmaceuticals & Drugs · Chairman: Ramesh Babu · MD: Ramesh Babu · Listing date: Feb. 28, 2007 · Employees: 1080 · Hyderabad · http://www.smspharma.com

Stock Price vs Company Growth
1d
1.8%
1w
5.7%
1m
7.6%
3m
29.5%
6m
44.4%
1y
84.5%
5y
27.7%
10y
17.3%
all
14.1%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 404 1.8%
294
434
Company Overview

Sales
897 Cr
Growth: 15.9%
Profit after Tax
89.6 Cr
Growth: 6.2%
Small Cap
3,779 Cr
P/E: 39.8x
Industry P/E: 27.1x
Fundamentals

Sales (Cr) ₹ 897
Growth 15.9%
EBITDA 19.2%
P/S 4.2x
Dividend 0.1%
P/E 39.8x
Book Value ₹ 75.8
PEG Ratio 2.5x
ROE 13.3%
P/B 5.3x
Shareholding Pattern

Institutions
Venkata Subbaraju Penmatsa .
2.13 %
Vivek Mundra
1.23 %
Aniruddh Mundra
1.13 %
Madhusudan Murlidhar Kela
1.1 %
Iepf
0.07 %
Promoters
Ramesh Babu Potluri
18.37 %
Hima Bindu Potluri
17.47 %
Vamsi Krishna Potluri
15.74 %
Potluri Infra Projects Llp
8.68 %
Trilok Potluri
2.58 %
Others
Increase    Decrease    No change
Company Profile Detailed

SMS Pharmaceuticals Ltd. is a global player in API manufacturing having strong research and manufacturing team supported by state of art facilities. What started off as a single facility single product manufacturing company in 1990 grew to be a multi location group having product list spreading across an array of therapeutic segments. SMS is currently a listed company having ever appreciating international and domestic customer base.
Investors (45)
Followers (1)